Transcatheter aortic valve replacements alter circulating serum factors to mediate myofibroblast deactivation
Journal Article
Overview
publication date
- September 11, 2019
has subject area
- Aortic Valve
- Biochemical Phenomena - MAP Kinase Signaling System
- Biochemical Phenomena - Signal Transduction
- Biochemical Phenomena - Transcriptome
- Body Fluids - Serum
- Cardiovascular Surgical Procedures - Transcatheter Aortic Valve Replacement
- Cell Cycle
- Cell Physiological Phenomena - MAP Kinase Signaling System
- Cell Physiological Phenomena - Signal Transduction
- Complex Mixtures - Hydrogels
- Environment and Public Health - Reproducibility of Results
- Female
- Fibroblasts - Myofibroblasts
- Gene Expression - Transcriptome
- Genetic Structures - Transcriptome
- Health Care Evaluation Mechanisms - Reproducibility of Results
- Hemic and Immune Systems - Serum
- Humans
- Inflammation Mediators
- Investigative Techniques - Reproducibility of Results
- Investigative Techniques - Reproducibility of Results
- Male
- Metabolic Networks and Pathways - MAP Kinase Signaling System
- Myocytes, Smooth Muscle - Myofibroblasts
- Pharmaceutical Preparations - Hydrogels
- Phenotype
- Prosthesis Implantation - Transcatheter Aortic Valve Replacement
- Sex Characteristics
- Thoracic Surgical Procedures - Transcatheter Aortic Valve Replacement
has restriction
- green
Date in CU Experts
- September 24, 2019 4:18 AM
Full Author List
- Aguado BA; Schuetze KB; Grim JC; Walker CJ; Cox AC; Ceccato TL; Tan A-C; Sucharov CC; Leinwand LA; Taylor MRG
author count
- 12
citation count
- 36
published in
- Science Translational Medicine Journal
Other Profiles
International Standard Serial Number (ISSN)
- 1946-6234
Electronic International Standard Serial Number (EISSN)
- 1946-6242
Digital Object Identifier (DOI)
Additional Document Info
volume
- 11
issue
- 509
number
- ARTN eaav3233